Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Forest, Nabriva In Development Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Forest, Nabriva In Development Pact

Forest to fund development of antibacterial agent

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Forest Laboratories, Inc. and Nabriva Therapeutics have entered into an agreement for the development of Nabriva’s antibacterial agent, BC-3781. Forest will provide $25 million and fund and conduct in collaboration with Nabriva, certain development activities related to BC-3781 for the next 12 months, during which Forest has the exclusive right to acquire Nabriva. The transaction is subject to customary regulatory clearances.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics